l carnitine deficiency causes Primary systemic Carnitine Metabolism and Deficiency Syndromes

This study demonstrates the efficiency of anamorelin in counteracting specific parameters of cancer cachexia in patients, leading to the approval of anamorelin as the first pharmacological intervention in cachexia in Japan

PMID: 36274487 Int J Mol Sci2022 May 16;23(10):5543

At 20 weeks, greater weight loss was observed in the cagrilintide plus semaglutide group15.7% for 1.2 mg of cagrilintide, and 17.1% for 2.4 mg of cagrilintide, while only 9.8% for semaglutide with placebo

"Alpha-lipoic acid and ALCAR on vascular function and blood pressure." J Clin Hypertens 2007;9(4):249-55

Work in GACs laboratory is supported by National Institutes of Health (NIH/NCATS) grant UH3TR00943-01 through the NIH Common Fund, Office of Strategic Coordination (OSC), the NCI grants 1R01 CA182905-01 and 1R01CA222007-01A1, an NIGMS 1R01GM122775-01 grant, a U54 grant #CA096297/CA096300 UPR/MDACC Partnership for Excellence in Cancer Research 2016 Pilot Project, a Team DOD (CA160445P1) grant, a Chronic Lymphocytic Leukemia Moonshot Flagship project, a Sister Institution Network Fund (SINF) 2017 grant, and the Estate of C

The protective effect of carnitine in human diphtheric myocarditis